Fundz

Who to call at Andelyn Biosciences, and when

Fundz watches for the moments Andelyn Biosciences starts buying, and tells you who to reach.

  • An alert the day Andelyn Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Andelyn Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Andelyn Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Andelyn Biosciences Partners with Celliaz to Develop Gene Therapy CLZ002 for Retinitis Pigmentosa.

Nov 12, 2026

Contract Type

partnership

ColumbusManufacturingBiotechnologyTherapeutics

Description

Andelyn Biosciences has formed a strategic partnership with Celliaz Co., Ltd. to develop CLZ002, an investigational gene therapy targeting retinitis pigmentosa. This gene-agnostic therapy aims to address the unmet need for effective treatments in retinal diseases.

Quick answer

Andelyn Biosciences Partners with Celliaz to Develop Gene Therapy CLZ002 for Retinitis Pigmentosa. (November 12, 2026). Andelyn Biosciences is based in Columbus, Ohio, United States.

What agreement did Andelyn Biosciences announce on November 12, 2026?
Andelyn Biosciences has formed a strategic partnership with Celliaz Co., Ltd. to develop CLZ002, an investigational gene therapy targeting retinitis pigmentosa. This gene-agnostic therapy aims to address the unmet need for effective treatments in retinal diseases.
What does Andelyn Biosciences do?
Andelyn Biosciences is a full-service cell and gene therapy CDMO focused on the development, characterization and production of viral vectors for gene therapy.
Where is Andelyn Biosciences based?
Andelyn Biosciences is based in Columbus, Ohio, United States.
Which similar companies announced agreements around the same time?
Sino Biopharmaceutical (November 13, 2026), OXB (November 17, 2026), Teva Pharmaceutical Industries Ltd (November 3, 2026) and AbbVie Inc. (November 3, 2026) also announced agreements within 45 days of Andelyn Biosciences.

Source: Fundz verified event record.

Other recent agreements in Therapeutics and Manufacturing

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Andelyn Biosciences

Location

Columbus, Ohio, United States

About

Andelyn Biosciences is a full-service cell and gene therapy CDMO focused on the development, characterization and production of viral vectors for gene therapy. With more than 20 years of experience, Andelyn's deep scientific expertise has resulted in the production of cGMP material for more than 450 clinical batches and 75 global clinical trials. Operating out of three Columbus, Ohio facilities, Andelyn supports its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cGMP clinical and commercial manufacturing. Andelyn's versatile capabilities include cGMP manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. An advanced digital model, quality system, full regulatory support and supply chain vertical integration help Andelyn accelerate the development and manufacturing of its clients' innovative cell and gene therapies. For more information, visit andelynbio.com.

Related People

Wade
Senior decision-maker at this company
••••••••@••••••••

See Wade's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Andelyn Biosciences's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Andelyn Biosciences signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.